ClinicalTrials.gg
Sign In

Hyperlipidemia, Familial Combined clinical trials

The registry lists 10 studies for Hyperlipidemia, Familial Combined across 6 countries. 0 are recruiting or about to start. 2 of them are mainly about Hyperlipidemia, Familial Combined (how this is decided). Per ClinicalTrials.gov, last updated 2025-05-09.

Status

Completed
8
Withdrawn
1
Status unknown
1

Phase

Early Phase 1
1
Phase 4
1
Phase 3
1

Where

United States
1
Germany
1
Netherlands
1
Mexico
1
Korea, Republic of
1
Switzerland
1

Who runs them

University of Washington (2) · Medical College of Wisconsin (1) · Radboud University Medical Center (1) · Daiichi Sankyo (1) · Kuhnil Pharmaceutical Co., Ltd. (1) · Sint Franciscus Gasthuis (1) · GWT-TUD GmbH (1) · University of California, Los Angeles (1)

What is being tested here

Drugs under test in Hyperlipidemia, Familial Combined studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Colesevelam001
Fenofibrate001
Chenodeoxycholic Acid001

Who these studies take

No Hyperlipidemia, Familial Combined study is recruiting now.

Across all 10 studies, recruiting or not: 30% stop at 75 or younger and 20% at 65; 30% take children; 0% are for women only and 10% for men only; 40% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 10 of 10. search them.